• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Analysis of ifosfamide, 4-hydroxyifosfamide, N2-dechloroethylifosfamide, N3-dechloroethylifosfamide and iphosphoramide mustard in plasma by gas chromatography-mass spectrometry.

作者信息

Wang J J, Chan K K

机构信息

School of Pharmacy, University of Southern California, Los Angeles 90033, USA.

出版信息

J Chromatogr B Biomed Appl. 1995 Dec 15;674(2):205-17. doi: 10.1016/0378-4347(95)00309-6.

DOI:10.1016/0378-4347(95)00309-6
PMID:8788150
Abstract

A sensitive and specific method for the simultaneous quantitation of ifosfamide (IF), 4-hydroxylifosfamide (4-OHIF), N2-dechloroethylifosfamide (N2D), N3-dechloroethylifosfamide (N3D) and iphosphoramide mustard (IPM) has been developed using gas chromatography-mass spectrometry (GC-MS) with an ion-trap mass spectrometer. Deuterium labeled analogues for each of these analytes were synthesized as the internal standards. The labile 4-OHIF in plasma was first converted to the more stable cyanohydrin adducts before dichloromethane extraction. IPM was extracted by C18 reversed-phase resin. All analytes were converted to their silyl derivatives before GC-MS analysis. The sensitivity limits ranged from 0.1 to 0.5 microgram/ml when 100 microliters of plasma was used. This method was validated with within-run coefficients of variation less than 5% (n = 8) and between-run coefficients of variation less than 12% (n = 6). The method was applied to the determination of plasma levels of IF and metabolites in the rat.

摘要

相似文献

1
Analysis of ifosfamide, 4-hydroxyifosfamide, N2-dechloroethylifosfamide, N3-dechloroethylifosfamide and iphosphoramide mustard in plasma by gas chromatography-mass spectrometry.
J Chromatogr B Biomed Appl. 1995 Dec 15;674(2):205-17. doi: 10.1016/0378-4347(95)00309-6.
2
Stereoselective pharmacokinetics of ifosfamide in male and female rats.异环磷酰胺在雄性和雌性大鼠体内的立体选择性药代动力学
AAPS PharmSci. 2000;2(2):E17. doi: 10.1208/ps020217.
3
Preclinical pharmacokinetics and stability of isophosphoramide mustard.异环磷酰胺氮芥的临床前药代动力学与稳定性
Cancer Chemother Pharmacol. 1994;33(5):391-8. doi: 10.1007/BF00686268.
4
Determination of 4-hydroxyifosfamide concomitantly with ifosfamide and its dechloroethylated metabolites using gas chromatography and a nitrogen phosphorus-selective detector.使用气相色谱法和氮磷选择性检测器同时测定异环磷酰胺及其脱氯乙基代谢物4-羟基异环磷酰胺。
J Chromatogr B Biomed Sci Appl. 1999 Sep 10;732(1):3-15. doi: 10.1016/s0378-4347(99)00254-6.
5
Effects of phenobarbital on stereoselective metabolism of ifosfamide in rats.
Drug Metab Dispos. 1998 May;26(5):476-82.
6
Differential in vitro hepatic and intestinal metabolism of ifosfamide in the rat.大鼠体内异环磷酰胺的体外肝脏和肠道代谢差异
Xenobiotica. 1998 Aug;28(8):779-84. doi: 10.1080/004982598239191.
7
Determination of ifosfamide, 2- and 3-dechloroethyifosfamide using gas chromatography with nitrogen-phosphorus or mass spectrometry detection.
Ther Drug Monit. 2000 Oct;22(5):613-20. doi: 10.1097/00007691-200010000-00018.
8
Simultaneous quantification of preactivated ifosfamide derivatives and of 4-hydroxyifosfamide by high performance liquid chromatography-tandem mass spectrometry in mouse plasma and its application to a pharmacokinetic study.
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jun 15;992:30-5. doi: 10.1016/j.jchromb.2015.04.025. Epub 2015 Apr 20.
9
Analysis of 4-hydroxycyclophosphamide by gas chromatography-mass spectrometry in plasma.
J Chromatogr. 1989 Oct 27;495:131-8. doi: 10.1016/s0378-4347(00)82616-x.
10
Chromatographic analysis of the enantiomers of ifosfamide and some of its metabolites in plasma and urine.异环磷酰胺及其某些代谢产物对映体在血浆和尿液中的色谱分析。
J Chromatogr B Biomed Sci Appl. 1997 Mar 7;690(1-2):131-8. doi: 10.1016/s0378-4347(96)00376-3.

引用本文的文献

1
An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect.一种肿瘤内的药代动力学/药效学模型用于缺氧激活前药依氟鸟氨酸(TH-302):单药活性不依赖旁观者效应。
Neoplasia. 2019 Feb;21(2):159-171. doi: 10.1016/j.neo.2018.11.009. Epub 2018 Dec 31.
2
Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.基于 UPLC-ESI-QTOFMS 的代谢组学研究在小鼠体内环磷酰胺和异环磷酰胺的比较代谢。
Biochem Pharmacol. 2010 Oct 1;80(7):1063-74. doi: 10.1016/j.bcp.2010.06.002. Epub 2010 Jun 10.
3
Stereoselective pharmacokinetics of ifosfamide in male and female rats.
异环磷酰胺在雄性和雌性大鼠体内的立体选择性药代动力学
AAPS PharmSci. 2000;2(2):E17. doi: 10.1208/ps020217.
4
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.异环磷酰胺及其代谢产物的临床药代动力学和药效学
Clin Pharmacokinet. 2001 Jan;40(1):41-62. doi: 10.2165/00003088-200140010-00004.